IN2015DN02601A - - Google Patents

Download PDF

Info

Publication number
IN2015DN02601A
IN2015DN02601A IN2601DEN2015A IN2015DN02601A IN 2015DN02601 A IN2015DN02601 A IN 2015DN02601A IN 2601DEN2015 A IN2601DEN2015 A IN 2601DEN2015A IN 2015DN02601 A IN2015DN02601 A IN 2015DN02601A
Authority
IN
India
Prior art keywords
present
dabigatran etexilate
preparation
hydrobromide salt
crystalline form
Prior art date
Application number
Other languages
English (en)
Inventor
Anandam Vempali
Sudhir Singh Sanwal
Balaguru Murugesan
Swargam Sathyanarayana
Rajesh Kumar Thaper
Mohan Prasad
Original Assignee
Ranbaxy Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Lab Ltd filed Critical Ranbaxy Lab Ltd
Priority to IN2601DEN2015 priority Critical patent/IN2015DN02601A/en
Publication of IN2015DN02601A publication Critical patent/IN2015DN02601A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/32—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of salts of sulfonic acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IN2601DEN2015 2012-09-28 2013-09-30 IN2015DN02601A (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IN2601DEN2015 IN2015DN02601A (fr) 2012-09-28 2013-09-30

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN3067DE2012 2012-09-28
IN2601DEN2015 IN2015DN02601A (fr) 2012-09-28 2013-09-30
PCT/IB2013/059017 WO2014049586A2 (fr) 2012-09-28 2013-09-30 Procédé de préparation d'étéxilate de dabigatran ou d'un sel pharmaceutiquement acceptable de cette substance

Publications (1)

Publication Number Publication Date
IN2015DN02601A true IN2015DN02601A (fr) 2015-09-18

Family

ID=49765595

Family Applications (1)

Application Number Title Priority Date Filing Date
IN2601DEN2015 IN2015DN02601A (fr) 2012-09-28 2013-09-30

Country Status (5)

Country Link
US (1) US20150225370A1 (fr)
EP (1) EP2900652A2 (fr)
CA (1) CA2886094A1 (fr)
IN (1) IN2015DN02601A (fr)
WO (1) WO2014049586A2 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108947966A (zh) * 2014-04-04 2018-12-07 江苏天士力帝益药业有限公司 达比加群酯甲磺酸盐新晶型及其制备方法
CN103951654B (zh) * 2014-05-13 2016-08-24 南京生命能科技开发有限公司 甲磺酸达比加群酯的晶体v及其制备方法
CN103965164A (zh) * 2014-05-13 2014-08-06 南京生命能科技开发有限公司 甲磺酸达比加群酯的晶体ⅵ及其制备方法
CN105348260A (zh) * 2014-08-19 2016-02-24 天津药物研究院 达比加群酯氢溴酸盐及其制备方法和应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6087380A (en) 1949-11-24 2000-07-11 Boehringer Ingelheim Pharma Kg Disubstituted bicyclic heterocycles, the preparations and the use thereof as pharmaceutical compositions
JP3866715B2 (ja) 2002-03-07 2007-01-10 ベーリンガー インゲルハイム ファルマ ゲゼルシャフト ミット ベシュレンクテル ハフツング ウント コンパニー コマンディトゲゼルシャフト ３−［（２−｛［４−（ヘキシルオキシカルボニルアミノ−イミノ−メチル）−フェニルアミノ］−メチル｝−１−メチル−１ｈ−ベンゾイミダゾール−５−カルボニル）−ピリジン−２−イル−アミノ］−プロピオン酸エチルエステル及びその塩の経口適用の投与形態
DE102005020002A1 (de) 2005-04-27 2006-11-02 Boehringer Ingelheim Pharma Gmbh & Co. Kg Physiologisch verträgliche Salze von 3-[(2-{[4-(Hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionsäure-ethylester
DE102005025728A1 (de) 2005-06-04 2006-12-07 Boehringer Ingelheim Pharma Gmbh & Co. Kg Polymorphe von 3-[(2-{[4-(Hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-Propionsäure-ethylester
US20100087488A1 (en) 2006-10-10 2010-04-08 Boehringer Ingelheim International Gmgh Physiologically Acceptable Salts of 3-[(2--1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionic acid ethyl ester
DE102006054005A1 (de) 2006-11-16 2008-05-21 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Polymorphe von 3-[(2-{[4-(Hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionsäure-ethylester
CA2734804A1 (fr) * 2008-08-19 2010-02-25 Boehringer Ingelheim International Gmbh Utilisation du dabigatran-etexilate pour le traitement de patients souffrant d'hypertension pulmonaire
EA201100358A1 (ru) * 2008-08-19 2011-10-31 Бёрингер Ингельхайм Интернациональ Гмбх Дабигатран для чрескожной хирургической катетеризации сердца
US20110306640A1 (en) * 2008-08-19 2011-12-15 Boehringer Ingelheim International Gmbh Dabigatran in tumour therapy
HUP1000069A2 (en) 2010-02-02 2012-05-02 Egis Gyogyszergyar Nyilvanosan M Kod Ruszvunytarsasag New salts for the preparation of pharmaceutical composition
US20130149346A1 (en) 2010-03-08 2013-06-13 ratiopharm GmbH Graf-Arco-Strasse 3 Dabigatran etexilate-containing pharmaceutical composition
WO2012027543A1 (fr) 2010-08-25 2012-03-01 Teva Pharmaceuticals Usa, Inc. Formes solides de dabigatran étexilate et de dabigatran étexilate mésylate et leurs méthodes de préparation
WO2012044595A1 (fr) 2010-09-27 2012-04-05 Ratiopharm Gmbh Mésylate de dabigatran étexilate, ses formes solides et leurs procédés de préparation
CN102558153A (zh) * 2012-02-08 2012-07-11 北京阜康仁生物制药科技有限公司 达比加群酯的新药用盐及其制备方法

Also Published As

Publication number Publication date
EP2900652A2 (fr) 2015-08-05
CA2886094A1 (fr) 2014-04-03
WO2014049586A2 (fr) 2014-04-03
WO2014049586A3 (fr) 2014-05-15
US20150225370A1 (en) 2015-08-13

Similar Documents

Publication Publication Date Title
SG10201808624VA (en) Polymorphs of selinexor
MX361653B (es) Procedimiento para la preparación de derivados del ácido biliar.
EA033513B1 (ru) Способы получения хинолиновых соединений и фармацевтических композиций, содержащих такие соединения
TW201613872A (en) IRAK4 inhibiting agents
IN2014MN02598A (fr)
MX351305B (es) Antagonistas del receptor de mineralocorticoides.
UA108926C2 (ru) LibreOffice? [2,3-D] +" +" !+
PH12015500460B1 (en) Coated pharmaceutical composition containing regorafenib
EA201490919A1 (ru) Производные бетулина
EA201290726A1 (ru) Новые соли для получения фармацевтических композиций
EA033455B1 (ru) Кристаллические формы замещенных 5-фтор-1h-пиразолопиридинов, способы их получения, их применение для получения лекарственного средства, лекарственное средство и способ лечения на их основе
IN2015DN02616A (fr)
EA201491149A1 (ru) Пиразолопиридиновые производные, способы их получения и их терапевтическое применение
WO2014192030A3 (fr) Procédé amélioré pour la préparation de l'étéxilate de dabigatran et sels d'addition acide pharmaceutiquement acceptables de celui-ci
WO2013111163A3 (fr) Procédé de préparation de dabigatran étéxilate mésylate et polymorphes d'intermédiaires de celui-ci
MX337721B (es) Compuestos de heteroarilo como ligandos del receptor 5-ht4.
MY183123A (en) Synthesis of copanlisib and its di hydrochloride salt
IN2014DN06964A (fr)
MX339858B (es) Compuestos novedosos como ligandos del receptor h3 de la histamina.
IN2015DN02601A (fr)
MD20160111A2 (ro) Derivaţi diheterociclici legaţi de cicloalchil
IN2014DN09451A (fr)
TN2015000095A1 (en) Macrolide derivatives, preparation thereof and therapeutic use thereof
MX360001B (es) Compuestos de acrilamida como ligandos receptores de histamina h3.
IN2013MU03565A (fr)